Based on the findings from our study and the existing literature, we recommend prophylactic dose aspirin in all CRC patients during CRT regardless of molecular profile without contraindications to treatment, given the low potential for harm and possibly significant benefit.
← all excerpts
Concurrent Aspirin Use Is Associated with Improved Outcome in Rectal Cancer Patients Who Undergo Chemoradiation Therapy.
1
—
—